President to sign bills aimed at increasing drug price transparency

BY 

WASHINGTON — President Donald Trump is scheduled to sign two pieces of legislation into law on Wednesday that aim to inform consumers about drug prices.

Both measures, the Know the Lowest Price Act and the Patient Right to Know Drug Prices Act, aim to end the drug industry’s so-called gag orders of pharmacists, which prevent them from discussing cheaper price options with consumers. These price options include discussing whether a medication may be less expensive if using insurance or paying out-of-pocket.

Some states and municipalities have pharmacy gag order bans, but the Patient Right to Know Drug Prices Act, sponsored by Maine Republican Sen. Susan Collins, addresses banning the practice of gag orders on a federal level. The Know the Lowest Price Act, sponsored by Michigan Democratic Sen. Debbie Stabenow, prohibits Medicare drug plans from putting a gag clause on a pharmacy in their contracts.

More: https://wreg.com/2018/10/10/president-to-sign-bills-aimed-at-increasing-drug-price-transparency/